| Literature DB >> 35567307 |
Ruth Pat-Horenczyk1, Miriam Schiff1, Aliriza Arënliu2, Larysa Zasiekina3, Antonios Kagialis4, Nuno Ferreira5, Yuriy Nesterko6, Heide Glaesmer6, Manuel Fernández-Alcántara7, Rami Benbenishty1,8.
Abstract
This study focused on the specific challenges of university students in the face of the COVID-19 pandemic and examined similarities and differences in COVID-related concerns and difficulties in functioning in samples of undergraduate students in five countries. A sample of 4306 undergraduate university students (43.8% males, 56.2% females) from Israel, Kosovo, Ukraine, Cyprus and Germany participated in an anonymous online survey during the first wave of the pandemic, between March and June 2020. Study variables included the assessment of the exposure to COVID-19, perceived health status, specific COVID-related concerns and functional difficulties, social support, and the perceived level of coping. Similar concerns about the uncertainty regarding the termination of the health crisis and worry for the health of family members were identified as the most common concerns in the five countries. Challenges in online learning and financial difficulties were rated as the most central difficulties. Both COVID-related concerns and COVID-related difficulties predicted lower levels of perceived coping. Greater social support was associated with better perceived coping. Policymakers should be informed by the accumulating research showing the substantive relationships between academic difficulties and perceived COVID-related distress and coping.Entities:
Keywords: COVID-19; Coping; International; University students
Mesh:
Year: 2022 PMID: 35567307 PMCID: PMC9348485 DOI: 10.1002/ijop.12846
Source DB: PubMed Journal: Int J Psychol ISSN: 0020-7594
Backgrounds characteristic in each country
| Israel (n = 2714) | Kosovo (n = 887) | Ukraine (n = 464) | Cyprus (n = 133) | Germany (n = 108) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total (n = 4392) | n | % | n | % | n | % | n | % | n | % | Tests | ||
| Gender | |||||||||||||
| Male | 1871 | 43.0 | 970 | 35.9 | 757 | 85.3 | 68 | 15.7 | 38 | 28.8 | 33 | 30.8 |
|
| Female | 2478 | 57.0 | 1734 | 64.1 | 130 | 14.7 | 365 | 84.3 | 94 | 71.2 | 74 | 69.2 | |
| Age | |||||||||||||
| Mean | 23.5 | 25.10 | 20.65 | 20.25 | 23.11 | 22.05 |
| ||||||
| ( | (3.86) | (3.51) | (2.28) | (1.64) | (3.04) | (2.99) | |||||||
|
Contagion % of Population | 0.00755% | 0.00032% | 0.00034% | 0.00265% | 0.00728% | ||||||||
New cases (% of population), April 1, 2020, based on: https://coronavirus.jhu.edu/data/cumulative‐cases.
Significantly (p < .001) different compared to Israel using Bonferroni alpha.
Significantly (p < .001) different compared to Kosovo using Bonferroni alpha.
Significantly (p < .001) different compared to Ukraine using Bonferroni alpha.
Exposure to COVID‐19 in each country (n/ %)
| Israel (n = 2714) | Kosovo (n = 887) | Ukraine (n = 464) | Cyprus (n = 133) | Germany (n = 108) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | χ2 (4) | |
| Was in quarantine due to infection or suspected infection (% of yes) | 297 | 11.0 | 13 | 1.5 | 5 | 1.1 | 12 | 9.1 | 11 | 10.2 | 116.37 Cramer's |
| Knows personally a person who was tested positive for COVID | 595 | 21.9 | 137 | 15.4 | 32 | 6.9 | 32 | 24.2 | 42 | 38.9 | 94.16 Cramer's |
| A family member/close friend was tested positive for COVID (%) | 156 | 5.8 | 32 | 3.6 | 1 | 0.2 | 10 | 7.6 | 12 | 11.1 | 40.11 Cramer's |
Descriptive statistics of COVID‐related concerns and their rank‐order in each participating country
| Israel (n = 2714) | Kosovo (n = 887) | Ukraine (n = 464) | Cyprus (n = 133) | Germany (n = 108) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | SD | Rank | M | SD | Rank | M | SD | Rank | M | SD | Rank | M | SD | Rank | F | |
| It is not clear when this state of emergency will end | 4.61 | 0.74 | 1 | 4.18 | 1.02 | 1 | 4.00 | 0.98 | 4 | 4.36 | 0.93 | 1 | 4.25 | 1.01 | 2 |
|
| The quick spreading of the virus around the world | 4.35 | 0.83 | 2 | 4.07 | 0.95 | 3 | 4.12 | 0.90 | 2 | 4.29 | 0.94 | 2 | 4.35 | 0.83 | 1 |
|
| The restrictions on your daily life due to the COVID‐19 virus | 4.30 | 0.87 | 3 | 3.70 | 1.20 | 5 | 3.84 | 1.01 | 5 | 4.10 | 1.03 | 3 | 3.77 | 1.00 | 3 |
|
| The growing number of infected people in the country | 4.20 | 0.87 | 4 | 3.91 | 0.98 | 4 | 4.06 | 0.88 | 3 | 3.81 | 0.97 | 5 | 3.71 | 0.91 | 4 |
|
| There is still no vaccination for the virus | 4.06 | 0.95 | 5 | 4.14 | 1.05 | 2 | 4.14 | 1.01 | 1 | 3.87 | 1.17 | 4 | 3.60 | 1.08 | 5 |
|
| The fact that any person may pass the virus to you | 3.92 | 0.93 | 6 | 3.63 | 1.05 | 6 | 3.54 | 0.89 | 6 | 3.79 | 0.96 | 6 | 3.27 | 0.78 | 6 |
|
| The protective measures (e.g., social distancing, personal hygiene) are not efficient enough | 3.76 | 1.00 | 7 | 3.25 | 1.17 | 7 | 3.34 | 1.09 | 7 | 3.71 | 1.10 | 7 | 3.14 | 0.92 | 7 |
|
| Total level of concerns (average of all items) | 4.17 | 0.60 | 3.83 | 0.77 | 3.85 | 0.68 | 4.00 | 0.70 | 3.73 | 0.54 | N/A |
| ||||
N/A Not applicable as this is an index of all items.
Significantly (p < .001) different compared to Israel using Bonferroni alpha.
Significantly (p < .001) different compared to Kosovo using Bonferroni alpha.
Significantly (p < .001) different compared to Ukraine using Bonferroni alpha.
Significantly (p < .001) different compared to Cyprus using Bonferroni alpha.
Descriptive statistics of COVID‐related functional difficulties and their rank‐order in each participating country
| Israel (n = 2714) | Kosovo (n = 887) | Ukraine (n = 464) | Cyprus (n = 133) | Germany (n = 108) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | SD | Rank | M | SD | Rank | M | SD | Rank | M | SD | Rank | M | SD | Rank | F | |
| Difficulty with learning | 3.02 | 0.98 | 1 | 2.30 | 1.05 | 1 | 2.76 | 1.11 | 1 | 2.65 | 1.09 | 1 | 2.44 | 1.03 | 1 |
|
| Using online learning | 2.80 | 1.04 | 2 | 2.12 | 1.02 | 3 | 2.70 | 1.12 | 2 | 2.30 | 1.08 | 2 | 1.99 | 0.96 | 2 |
|
| Loneliness | 2.39 | 1.07 | 3 | 1.91 | 0.97 | 4 | 1.99 | 1.07 | 4 | 2.15 | 1.07 | 4 | 1.89 | 1.01 | 3 |
|
| Boredom | 2.23 | 1.07 | 4 | 2.27 | 0.96 | 2 | 2.50 | 1.15 | 3 | 2.27 | 1.05 | 3 | 1.46 | 0.74 | 4 |
|
| Total (M) difficulties | 2.61 | 0.72 | N/A | 2.15 | 0.76 | N/A | 2.49 | 0.81 | N/A | 2.34 | 0.77 | N/A | 1.95 | 0.66 | N/A |
|
Significantly (p < .001) different compared to Israel using Bonferroni Alpha.
Significantly (p < .001) different compared to Kosovo using Bonferroni Alpha.
Significantly (p < .001) different compared to Ukraine using Bonferroni Alpha.
Descriptive statistics of variables in the regression
| different from Israel | Mean | SD | Median | Skewness | Kurtosis | Shapiro–Wilk |
|---|---|---|---|---|---|---|
| Coping | 7.39 | 2.03 | 8.00 | −0.89 | 0.45 | 0.91 |
| Age | 23.48 | 3.753 | 23.00 | 2.508 | 20.528 | 0.86 |
| Health | 4.40 | 0.738 | 5.00 | −1.132 | 1.071 | 0.75 |
| Concern | 3.19 | 0.81 | 3.29 | −0.21 | 0.08 | 0.99 |
| CRD | 2.43 | 0.64 | 2.43 | 0.06 | −0.52 | 0.99 |
| Exposure | 1.14 | 0.29 | 1.00 | 2.59 | 7.49 | 0.54 |
| Support | 7.91 | 2.29 | 8.00 | −1.17 | 0.82 | 0.85 |
p < .001 in test of deviation from normal distribution.
Hierarchical regression results analysis for coping
| 95% CI for B | ||||||||
|---|---|---|---|---|---|---|---|---|
| Variable | B | LL | UL | SE B | β | R2 | ΔR2 | |
| Step 1 | 0.8 | 0.8 | ||||||
| Constant | 7.33*** | 7.14 | 7.52 | 0.10 | ||||
| Israel | −0.05 | −0.25 | 0.15 | 0.10 | −0.01 | |||
| Cyprus | 0.11 | −0.29 | 0.51 | 0.20 | 0.01 | |||
| Germany | 0.13 | −0.30 | 0.56 | 0.22 | 0.01 | |||
| Kosovo | 0.42*** | 0.19 | 0.65 | 0.12 | 0.08*** | |||
| Step 2 | 1.6 | 0.8 | ||||||
| Constant | 7.66*** | 7.12 | 8.20 | 0.28 | ||||
| Israel | −0.19 | −0.42 | 0.03 | 0.11 | −0.05 | |||
| Cyprus | 0.02 | −0.38 | 0.42 | 0.20 | 0.00 | |||
| Germany | 0.06 | −0.37 | 0.49 | 0.00 | ||||
| Kosovo | 0.17 | −0.08 | 0.42 | 0.03 | ||||
| Age | 0.02 | 0.00 | 0.04 | 0.03 | ||||
| Gender (female) | −0.36*** | −0.50 | −0.22 | −0.09*** | ||||
| Step 3 | 12.6 | 11.0 | ||||||
| Constant | 3.70*** | 3.09 | 4.32 | |||||
| Israel | −0.51*** | −0.72 | −0.30 | −0.12*** | ||||
| Cyprus | 0.40 | 0.02 | 0.78 | 0.03 | ||||
| Germany | 0.11 | −0.30 | 0.51 | 0.01 | ||||
| Kosovo | −0.33** | −0.57 | −0.10 | −0.07** | ||||
| Age | 0.01 | 0.00 | 0.03 | 0.03 | ||||
| Gender (female) | −0.26*** | −0.39 | −0.13 | −0.06*** | ||||
| Health Status | 0.95*** | 0.86 | 1.03 | 0.04 | 0.34*** | |||
| Exposure to COVID‐19 | −0.23** | −0.40 | −0.06 | 0.09 | −0.04** | |||
| Step 4 | 19.1 | 6.5 | ||||||
| Constant | 5.96*** | 5.32 | 6.60 | 0.33 | ||||
| Israel | −0.13 | −0.34 | 0.08 | 0.11 | −0.03 | |||
| Cyprus | 0.52** | 0.15 | 0.88 | 0.19 | 0.04** | |||
| Germany | 0.01 | −0.38 | 0.41 | 0.20 | 0.00 | |||
| Kosovo | −0.23 | −0.46 | 0.00 | 0.12 | −0.04 | |||
| Age | 0.01 | −0.01 | 0.03 | 0.01 | 0.01 | |||
| Gender (female) | −0.06 | −0.19 | 0.07 | 0.07 | −0.02 | |||
| Health status | 0.83*** | 0.75 | 0.91 | 0.04 | 0.30*** | |||
| Exposure to Covid | −0.16 | −0.33 | 0.00 | 0.08 | −0.03 | |||
| Covid‐related concerns | −0.68*** | −0.76 | −0.61 | 0.04 | −0.27*** | |||
| Step 5 | 26.6 | 7.5 | ||||||
| Constant | 8.64*** | 7.98 | 9.31 | 0.34 | ||||
| Israel | −0.06 | −0.26 | 0.14 | 0.10 | −0.01 | |||
| Cyprus | 0.17 | −0.17 | 0.52 | 0.18 | 0.01 | |||
| Germany | −0.66*** | −1.04 | −0.28 | 0.19 | −0.05 | |||
| Kosovo | −0.40*** | −0.62 | −0.18 | 0.11 | −0.08 | |||
| Age | 0.00 | −0.02 | 0.01 | 0.01 | −0.01 | |||
| Gender (female) | −0.03 | −0.15 | 0.09 | 0.06 | −0.01 | |||
| Health status | 0.63*** | 0.55 | 0.71 | 0.04 | 0.23*** | |||
| Exposure to Covid | −0.11 | −0.27 | 0.05 | 0.08 | −0.02 | |||
| Covid‐related concerns | −0.39*** | −0.46 | −0.31 | 0.04 | −0.16*** | |||
| Covid‐related difficulties | −1.04*** | −1.14 | −0.94 | 0.05 | −0.33*** | |||
| Step 6 | 33.0 | 6.4 | ||||||
| Constant | 6.55*** | 5.88 | 7.21 | 0.34 | ||||
| Israel | 0.14 | −0.05 | 0.33 | 0.10 | 0.03 | |||
| Cyprus | 0.39* | 0.06 | 0.73 | 0.17 | 0.03* | |||
| Germany | −0.44* | −0.80 | −0.07 | 0.19 | −0.03* | |||
| Kosovo | −0.31 | −0.52 | −0.10 | 0.11 | −0.06 | |||
| Age | 0.01 | −0.01 | 0.02 | 0.01 | 0.01 | |||
| Gender (female) | −0.12* | −0.24 | 0.00 | 0.06 | −0.03* | |||
| Health status | 0.52*** | 0.44 | 0.59 | 0.04 | 0.19*** | |||
| Exposure to Covid | −0.09 | −0.24 | 0.06 | 0.08 | −0.02 | |||
| Covid‐related concerns | −0.43*** | −0.50 | −0.35 | 0.04 | −0.17*** | |||
| Covid‐related difficulties | −0.82*** | −0.91 | −0.72 | 0.05 | −0.26*** | |||
| Support | 0.25*** | 0.22 | 0.27 | 0.01 | 0.27*** | |||
Note: CI = confidence interval; LL = lower limit; UL = upper limit.
*p < .05. **p < .01. ***p < .001.